These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 30597181

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.
    Dodu JC, Moncayo RK, Damaj MI, Schlosburg JE, Akbarali HI, O'Brien LD, Kendall DA, Wu Z, Lu D, Lichtman AH.
    J Pharmacol Exp Ther; 2022 Jan; 380(1):1-14. PubMed ID: 34625464
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.
    Kinsey SG, Nomura DK, O'Neal ST, Long JZ, Mahadevan A, Cravatt BF, Grider JR, Lichtman AH.
    J Pharmacol Exp Ther; 2011 Sep; 338(3):795-802. PubMed ID: 21659471
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice.
    Trexler KR, Nass SR, Crowe MS, Gross JD, Jones MS, McKitrick AW, Siderovski DP, Kinsey SG.
    Drug Alcohol Depend; 2018 Oct 01; 191():14-24. PubMed ID: 30071445
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects.
    Ignatowska-Jankowska BM, Baillie GL, Kinsey S, Crowe M, Ghosh S, Owens RA, Damaj IM, Poklis J, Wiley JL, Zanda M, Zanato C, Greig IR, Lichtman AH, Ross RA.
    Neuropsychopharmacology; 2015 Dec 01; 40(13):2948-59. PubMed ID: 26052038
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
    Gamage TF, Ignatowska-Jankowska BM, Wiley JL, Abdelrahman M, Trembleau L, Greig IR, Thakur GA, Tichkule R, Poklis J, Ross RA, Pertwee RG, Lichtman AH.
    Behav Pharmacol; 2014 Apr 01; 25(2):182-5. PubMed ID: 24603340
    [Abstract] [Full Text] [Related]

  • 12. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
    Schlosburg JE, Carlson BL, Ramesh D, Abdullah RA, Long JZ, Cravatt BF, Lichtman AH.
    AAPS J; 2009 Jun 01; 11(2):342-52. PubMed ID: 19430909
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 01; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

  • 14. Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice.
    Eckard ML, Kinsey SG.
    Neuropharmacology; 2021 Jun 01; 190():108554. PubMed ID: 33845073
    [Abstract] [Full Text] [Related]

  • 15. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M, Bindila L, Lutz B, Zimmer A, Bilkei-Gorzo A, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun 01; 389(6):603-12. PubMed ID: 26984820
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
    DeLong GT, Wolf CE, Poklis A, Lichtman AH.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):126-33. PubMed ID: 20619971
    [Abstract] [Full Text] [Related]

  • 17. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L, Guindon J, Cornett BL, Makriyannis A, Mackie K, Hohmann AG.
    Biol Psychiatry; 2015 Mar 01; 77(5):475-87. PubMed ID: 24853387
    [Abstract] [Full Text] [Related]

  • 18. Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.
    Huang P, Liu-Chen LY, Unterwald EM, Cowan A.
    Neurosci Lett; 2009 Nov 06; 465(1):66-70. PubMed ID: 19733208
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Kinsey SG, O'Neal ST, Long JZ, Cravatt BF, Lichtman AH.
    Pharmacol Biochem Behav; 2011 Mar 06; 98(1):21-7. PubMed ID: 21145341
    [Abstract] [Full Text] [Related]

  • 20. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH, Fisher J, Martin BR.
    Pharmacol Biochem Behav; 2001 Mar 06; 69(1-2):181-8. PubMed ID: 11420084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.